PLATO bleeding criteria: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
== | ==PLATO Bleeding Criteria== | ||
'''PLATO Bleeding Classification''' <ref name="pmid15842354">{{cite journal| author=Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis| title=Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. | journal=J Thromb Haemost | year= 2005 | volume= 3 | issue= 4 | pages= 692-4 | pmid=15842354 | doi=10.1111/j.1538-7836.2005.01204.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15842354 }} </ref> | |||
{{cquote| | {{cquote| | ||
===1. Major | ===1. Major Life-Threatening:=== | ||
*Fatal | *Fatal | ||
*[[Intracranial hemorrhage|Intracranial]] | *[[Intracranial hemorrhage|Intracranial]] | ||
| Line 16: | Line 15: | ||
*Requiring transfusion of ≥4 U whole blood or PRBCs | *Requiring transfusion of ≥4 U whole blood or PRBCs | ||
=====Other | =====Other Major===== | ||
*Significantly disabling (eg, intraocular with permanent vision loss) | *Significantly disabling (eg, intraocular with permanent vision loss) | ||
*Associated drop in [[hemoglobin]] of 3 to 5 g/dL | *Associated drop in [[hemoglobin]] of 3 to 5 g/dL | ||
*Requiring transfusion of 2 to 3 U whole blood or PRBCs | *Requiring transfusion of 2 to 3 U whole blood or PRBCs | ||
=====Any major===== | M=====Any major===== | ||
*Any one of the above criteria | *Any one of the above criteria | ||
| Line 32: | Line 31: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:primary care]] | |||
[[Category:Medical emergencies]] | [[Category:Medical emergencies]] | ||
[[Category:Blood]] | [[Category:Blood]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 17:37, 27 March 2013
|
Bleeding Microchapters |
|
Treatment |
|---|
|
Reversal of Anticoagulation and Antiplatelet in Active Bleed |
|
Perioperative Bleeding |
|
PLATO bleeding criteria On the Web |
|
American Roentgen Ray Society Images of PLATO bleeding criteria |
|
Risk calculators and risk factors for PLATO bleeding criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
PLATO Bleeding Criteria
PLATO Bleeding Classification [1]
| “ | Insert the text of the quote here, without quotation marks. | ” |
References
- ↑ Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (2005). "Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients". J Thromb Haemost. 3 (4): 692–4. doi:10.1111/j.1538-7836.2005.01204.x. PMID 15842354.